Trial Profile
Comparison of Fenofibric Acid Bioavailability From 45 mg and 135 mg Strength ABT-335 Capsules.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Oct 2010
Price :
$35
*
At a glance
- Drugs Choline fenofibrate (Primary)
- Indications Hyperlipidaemia
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Abbott Laboratories
- 23 Apr 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 03 Mar 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 13 Feb 2009 New trial record